Literature DB >> 17675408

Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.

Tania Rinaldi1, Karina Kulangara, Katia Antoniello, Henry Markram.   

Abstract

Valproic acid (VPA) is a powerful teratogen causing birth defects in humans, including autism spectrum disorder (ASD), if exposure occurs during the first trimester of embryogenesis. Learning and memory alterations are common symptoms of ASD, but underlying molecular and synaptic alterations remain unknown. We therefore studied plasticity-related mechanisms in the neocortex of 2-week-old rats prenatally exposed to VPA and tested for changes in glutamate-mediated transmission and plasticity in the neocortex. We found a selective overexpression of NR2A and NR2B subunits of NMDA receptors, as well as the commonly linked kinase calcium/calmodulin-dependent protein kinase II. Synaptic plasticity experiments between pairs of pyramidal neurons revealed an augmented postsynaptic form of long-term potentiation. These results indicate that VPA significantly enhances NMDA receptor-mediated transmission and causes increased plasticity in the neocortex. Enhanced plasticity introduces a surprising perspective to the potential molecular and synaptic mechanisms involved in children prenatally exposed to VPA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675408      PMCID: PMC1948920          DOI: 10.1073/pnas.0704391104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  A study of memory functioning in individuals with autism.

Authors:  L Mottron; K Morasse; S Belleville
Journal:  J Child Psychol Psychiatry       Date:  2001-02       Impact factor: 8.982

Review 2.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

3.  Distribution of N-methyl-D-aspartate receptors (NMDARs) in the developing rat brain.

Authors:  Hirotake Takai; Kei-ichi Katayama; Koji Uetsuka; Hiroyuki Nakayama; Kunio Doi
Journal:  Exp Mol Pathol       Date:  2003-08       Impact factor: 3.362

4.  Fetal valproate syndrome and autism: additional evidence of an association.

Authors:  G Williams; J King; M Cunningham; M Stephan; B Kerr; J H Hersh
Journal:  Dev Med Child Neurol       Date:  2001-03       Impact factor: 5.449

5.  Source memory in children with autism spectrum disorders.

Authors:  Angela Garcia O'Shea; Deborah A Fein; Antonius H N Cillessen; Ami Klin; Robert T Schultz
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

6.  Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism.

Authors:  J L Ingram; S M Peckham; B Tisdale; P M Rodier
Journal:  Neurotoxicol Teratol       Date:  2000 May-Jun       Impact factor: 3.763

7.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

8.  Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism.

Authors:  Mark E Stanton; Elizabeth Peloso; Kevin L Brown; Patricia Rodier
Journal:  Behav Brain Res       Date:  2006-11-29       Impact factor: 3.332

9.  Characteristics of fetal anticonvulsant syndrome associated autistic disorder.

Authors:  A D Rasalam; H Hailey; J H G Williams; S J Moore; P D Turnpenny; D J Lloyd; J C S Dean
Journal:  Dev Med Child Neurol       Date:  2005-08       Impact factor: 5.449

Review 10.  Searching for ways out of the autism maze: genetic, epigenetic and environmental clues.

Authors:  Antonio M Persico; Thomas Bourgeron
Journal:  Trends Neurosci       Date:  2006-06-30       Impact factor: 13.837

View more
  111 in total

1.  Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.

Authors:  Lindsay Oberman; Mark Eldaief; Shirley Fecteau; Fritz Ifert-Miller; Jose Maria Tormos; Alvaro Pascual-Leone
Journal:  Eur J Neurosci       Date:  2012-06-28       Impact factor: 3.386

Review 2.  Neurophysiological and computational principles of cortical rhythms in cognition.

Authors:  Xiao-Jing Wang
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

3.  Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

Authors:  M J Gandal; R L Anderson; E N Billingslea; G C Carlson; T P L Roberts; S J Siegel
Journal:  Genes Brain Behav       Date:  2012-08       Impact factor: 3.449

4.  Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.

Authors:  Graham Atkin; Shannon Moore; Yuan Lu; Rick F Nelson; Nathan Tipper; Gautam Rajpal; Jack Hunt; William Tennant; Johannes W Hell; Geoffrey G Murphy; Henry Paulson
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

5.  Translational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells.

Authors:  Se Jin Jeon; Ji-Woon Kim; Ki Chan Kim; So Min Han; Hyo Sang Go; Jung Eun Seo; Chang Soon Choi; Jong Hoon Ryu; Chan Young Shin; Mi-Ryoung Song
Journal:  Cell Mol Neurobiol       Date:  2013-12-12       Impact factor: 5.046

6.  Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

Authors:  Lauren L Jantzie; Delia M Talos; Michele C Jackson; Hyun-Kyung Park; Dionne A Graham; Mirna Lechpammer; Rebecca D Folkerth; Joseph J Volpe; Frances E Jensen
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

7.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Authors:  Paula A Desplats; James R Lambert; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2008-05-22       Impact factor: 5.996

8.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

9.  Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.

Authors:  Anwesha Banerjee; Francisco García-Oscos; Swagata Roychowdhury; Luis C Galindo; Shawn Hall; Michael P Kilgard; Marco Atzori
Journal:  Int J Neuropsychopharmacol       Date:  2012-12-11       Impact factor: 5.176

10.  Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action.

Authors:  Zhi-Gang Yao; Liang Liang; Yu Liu; Ling Zhang; Hua Zhu; Lan Huang; Chuan Qin
Journal:  Cell Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.